Fordyce Marshall

CIK 00018594531 companyBRISBANE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001859453

Recent Transactions

50 trades

Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2025-02-26$27.55/sh−7,975→ 205,765 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2025-02-26$28.32/sh−1,100→ 204,665 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2025-02-21$27.89/sh−10,613→ 213,740 total
Award
Vera Therapeutics, Inc.$VERA
Stock Option (right to buy)
2025-02-18+161,500→ 161,500 total
Award
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2025-02-18+80,750→ 224,353 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Stock Option (Right to Buy)
2025-01-08−15,625→ 610,926 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2025-01-08$2.90/sh+5,650→ 149,253 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2025-01-08$2.90/sh+9,975→ 153,578 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2025-01-08$41.53/sh−9,975→ 143,603 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2025-01-08$2.90/sh+1,875→ 145,478 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2025-01-08$42.00/sh−1,875→ 143,603 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Stock Option (Right to Buy)
2025-01-08−1,875→ 609,051 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2025-01-08$42.03/sh−5,650→ 143,603 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-12-19$2.90/sh+57,661→ 143,603 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Stock Option (Right to Buy)
2024-12-19−57,661→ 626,551 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-12-18$43.52/sh−5,023→ 85,942 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Stock Option (Right to Buy)
2024-12-18−1,875→ 684,212 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Stock Option (Right to Buy)
2024-12-18−15,625→ 686,087 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-12-18$43.81/sh−1,875→ 85,942 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-12-18$2.90/sh+3,772→ 89,714 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-12-18$44.03/sh−4,635→ 85,942 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-12-18$42.35/sh−2,195→ 85,942 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-12-18$41.33/sh−3,772→ 85,942 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-12-18$2.90/sh+4,635→ 90,577 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-12-18$2.90/sh+1,875→ 87,817 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-12-18$2.90/sh+2,195→ 88,137 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-12-18$2.90/sh+5,023→ 90,965 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-12-11$46.94/sh−1,775→ 85,942 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-12-11$46.91/sh−14,925→ 85,942 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-12-11$2.90/sh+100→ 86,042 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-12-11$2.90/sh+14,925→ 100,867 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Stock Option (Right to Buy)
2024-12-11−1,875→ 701,712 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-12-11$2.90/sh+1,775→ 87,717 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-12-11$47.55/sh−700→ 85,942 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-12-11$2.90/sh+700→ 86,642 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-12-11$47.65/sh−100→ 85,942 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Stock Option (Right to Buy)
2024-12-11−15,625→ 703,587 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Stock Option (Right to Buy)
2024-11-25−1,875→ 721,087 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-11-25$47.05/sh−6,579→ 85,942 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-11-25$2.90/sh+1,875→ 87,817 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-11-25$2.90/sh+6,579→ 92,521 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-11-25$48.76/sh−1,875→ 85,942 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-11-25$2.90/sh+1,381→ 87,323 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-11-25$48.18/sh−7,665→ 85,942 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Stock Option (Right to Buy)
2024-11-25−1,875→ 719,212 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-11-25$2.90/sh+7,665→ 93,607 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Stock Option (Right to Buy)
2024-11-25−15,625→ 722,962 total
Exercise/Conversion
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-11-25$2.90/sh+1,875→ 87,817 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-11-25$49.00/sh−1,875→ 85,942 total
Sale
Vera Therapeutics, Inc.$VERA
Class A Common Stock
2024-11-25$48.80/sh−1,381→ 85,942 total

Companies

Vera Therapeutics, Inc.
Director, PRESIDENT AND CEO
$VERA

Recent Filings

Address

C/O VERA THERAPEUTICS, INC. 2000 SIERRA POINT PARKWAY, SUITE 1200

BRISBANE, CA, 94005

View on SEC.gov